Total Funding
28
42
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
46631
KELIX bio is a specialty generic business focused on delivering high complexity products to underserved populations across emerging markets.
Acquired by 
Mubadala
Ruchita Gandhi: Chief Financial Officer- Irfan Ahmed: Group Risk & Compliance Director
About the Company
KELIX bio is a specialty generic business focused on delivering high complexity products to underserved populations across emerging markets. Kelix Bio is a biotechnology company focused on developing advanced biological solutions for healthcare and life sciences. It works on innovative research, diagnostics, and therapeutic technologies to improve
patient outcomes. The company integrates science and technology to address complex medical challenges and support advancements in modern biotechnology and personalized medicine.
